Name (Synonyms) | Correlation | |
---|---|---|
drug3225 | chronic pain team Wiki | 1.00 |
drug915 | Dornase Alfa Wiki | 1.00 |
There is one clinical trial.
This was a prospective observational study with the primary objective of quantifying a change in pain scores after 6-12 months of two separate interventions within the study site (pain team and chiropractic team). Target enrollment was 30 participants for each intervention. The primary outcome was a change from baseline of the Pain Disability Questionnaire (PDQ), the study tool. Secondary outcomes were reduction of opioid dose by morphine equivalent daily dose, and its effect on PDQ scores.
Description: 6-12 month follow up pain score - (minus) baseline. scores range from 0 (no pain or disability) to 150 (severe pain and disability)
Measure: change in Pain Disability Questionnaire (PDQ) score Time: 6-12 monthDescription: ability to successfully wean off opioid prescription
Measure: prescription opioid weaning Time: 6-12 months